Idea
Where the idea comes from
Patients ask about procedures, not about devices. Someone who has laser eye surgery says LASIK or SMILE, not the name of the laser. For lens surgery with the nanolaser there has been no such term so far. Every practice explained the procedure in its own words, with its own images and its own messages, and in other countries distributors developed their material from scratch each time.
Christin Bartlog and Zoe Geiß of A.R.C. Laser turned this into a discussion starter for the User Meeting 2026: a shared procedure brand, led by A.R.C. Laser, available to all users, nationally and internationally. The draft was called NanoPURE and already contained the symbol, colors, claims, imagery and the division of roles. This portal develops the draft into a binding set of rules so that everything created under the name from now on fits together.
What the brand is meant to do. The brand makes the procedure recognizable, gives practices ready-made material and saves every market the cost of its own development. It is the reason to have the procedure done at this particular practice.
Decision of October 2026
At the end of October 2026, A.R.C. Laser (product management, Christin Bartlog) decided on the name. NanoPURE becomes PURE. The symbol, the colors and the typefaces stay as they were developed for the draft. New is the variation PURE by CETUS, in which the device is named in small type.
Shorter
One word, four letters, pronounced the same in every language. Patients say “PURE”, not “NanoPURE”.
Device reference optional
Toward patients, PURE stands alone. Toward professional audiences, “by CETUS” shows what the procedure is done with.
Old name conflicts
NanoPURE collides with the registered EU figurative mark “nanopure” in class 10 (EUIPO 018351781). See Trademark check.
- The name is PURE. No more concepts A, B or C, no switcher. Other name candidates from the discussion are closed and do not appear here.
- The symbol stays: navy arc and seven petrol dots, construction unchanged.
- Colors stay: navy, petrol, mint. Headings in Geist instead of IBM Plex Serif since October 31, 2026, text in IBM Plex Sans.
- One brand without tiers. The “pro” tier from the draft is not part of the decision, see Open items.
- Portal at purebrand.arclaser.cloud. The old portal remains as an archive and points here.
Starting point
Procedure brands shape the market
Patients know terms like LASIK or SMILE by name. For lens surgery with the nanolaser, no such term exists.
Every practice communicates differently
Different names, images and messages. Patients do not recognize the procedure from one practice to the next.
No shared presence internationally
Distributors and users in other countries develop their material anew each time, with their own effort and their own result.
The technology behind it is the CETUS NanoLaser: ultrashort pulses of an Nd:YAG laser in the nanosecond range are fully absorbed in the titanium needle of the single-use probe. A small flash of light (plasma) forms in the cavity and supplies the energy to break up the lens. The lens material is aspirated through the existing fluidics, so the familiar workflow remains. No ultrasound, no ultrasonic oscillation of the needle, no ultrasonic heat at the incision. The clinical evidence and its limits are described in the Regulatory section.
The device in numbers
| Parameter | Value | Source |
|---|---|---|
| Laser type | Q-switched Nd:YAG, 1,064 nm, pulsed | Manufacturer (arclaser.com) |
| Pulse duration | 5 ns (sources state 4 to 7 ns, to be clarified in the operating manual) | Manufacturer, ExpertGuide |
| Pulse energy | 3 to 10 mJ | Manufacturer |
| Repetition rate | up to 10 Hz (ExpertGuide states up to 25 Hz) | Manufacturer, Sauder 2024 |
| Laser class | Class 1, no protective eyewear required | Manufacturer |
| Probe | Single-use, about 30 g, titanium plate in the tip, sleeves 2.2 and 2.6 mm | Manufacturer, Sauder 2024 |
| Connection | Trigger tubing on the pneumatic vitrectomy port of the phaco machine, controlled via its footswitch | Manufacturer |
| Device | 478 × 135 × 421 mm, 12 kg, 110 to 240 V | Manufacturer |
| Approval | CE under 93/42/EEC according to the 07/2025 brochure; MDR status and FDA status not documented, open | Brochure, arclaser.com |
What happens next
The concept was put up for discussion at the User Meeting 2026. Four questions were on the table: Would you use a shared procedure brand in your practice? Which components would be most valuable? How do you like the name? What do you need in order to actively talk to patients about the procedure? The question of the name was answered in October 2026.
- Evaluate feedbackRight after the user meeting. Responses on name, components and needs. Decision for PURE.
- Develop the conceptA.R.C. Laser. Rules, logo system with two forms, claims, trademark search. This portal.
- Pilot with interested practicesUse the material in a few practices, train the consultation, gather experience.
- National and international rolloutPackage for distributors, languages of the target markets, country-specific review.
Brand
Brand core
Target group
People aged about 50 and up
Cataract and refractive lens exchange for presbyopia. People who want to see well and make a conscious decision for treatment.
Promise
Laser instead of ultrasound
Lens surgery without ultrasound, with low energy input. The draft said “precise and gentle with a premium claim”; “precise” is not substantiated and is not used, see Changes.
Evidence
CETUS NanoLaser
Laser-based lens fragmentation instead of ultrasound. The technology is the reason the promise holds, and it appears in the logo toward professional audiences as “by CETUS”.
All statements directed at patients are reviewed for regulatory compliance before use (German Health Advertising Act, Medical Device Regulation, professional code for physicians). See Regulatory.
Positioning
Guiding statement
“Laser instead of ultrasound.”
A fact, not a promise. Patients decide on the procedure and thereby on the practice that offers it.
What is not carried over from the draft. The earlier guiding statement “Your premium lens deserves a gentle procedure” tied the benefit of the procedure to the purchase of a premium lens and promised “gentle” without evidence (Sections 3 and 11 (1) no. 7 HWG, Section 5 UWG, Section 27 MBO). It has been removed and will not be reintroduced.
The positioning does not start with the device but with the decision the patient makes anyway: How should the lens be removed? PURE answers that with a verifiable property, not with a feeling. Competitors are neither named nor disparaged. The procedure explains itself through its own properties.
Attitude and character
PURE speaks like an experienced physician who takes her time: competent, calm, attentive. Medically precise, but never cold. The design follows the same attitude: light, soft, plenty of air, no hard edges, no signal colors.
| This is PURE | This is not PURE |
|---|---|
| Competent: explains, substantiates, sticks to the facts | Lecturing, with jargon left untranslated |
| Calm: quiet images, round shapes, light surfaces | Loud, garish, with laser beams and close-ups of the eye |
| Approachable: addresses people, not cases | Salesy, with superlatives and pressure |
| Reliable: one voice in every practice and every country | Arbitrary, different from practice to practice |
| High quality: premium through restraint | Luxurious, with gold, gloss and pathos |
Name and spelling
The brand is called PURE. Always in capitals, including in running text. Toward professional audiences it is called PURE by CETUS: “by” in lowercase, “CETUS” in capitals, three words with spaces.
The name stands for “purely laser, no ultrasound”, that is, for the one verifiable property of the procedure (“100 % laser. 0 % ultrasound.”). It does not stand for purity, sterility or freedom from side effects and is never explained that way. The acronym from the draft (P, U, R, E for Precise, Ultrasound-free, Resolution, Extraction) is not part of the decision; “Precise” was not substantiated anyway.
- Correct toward patients: PURE
- Correct toward professional audiences: PURE by CETUS
- Correct as a procedure description: PURE, lens surgery with the CETUS NanoLaser
- Correct as the device: CETUS NanoLaser (long form), CETUS (short form), toward patients “the nanolaser”
- Pure, pure, NanoPURE (the old name)
- PURE BY CETUS, Pure by Cetus, PURE/CETUS, PURE CETUS, CETUS PURE
- “the PURE” as a device name. PURE is the procedure, the device is called CETUS.
- “by CETUS” on its own, without PURE in front of it.
- Hyphenating the name at a line break or splitting it into syllables.
In technical identifiers everything stays lowercase: pure and pure-by-cetus
in file names, addresses and code. That is the boundary between running text and identifier, not a
contradiction of the spelling rule.
The sender is in every case A.R.C. Laser GmbH. The manufacturer’s website has so far spelled the device inconsistently (Cetus NanoLaser, CETUS Nano-Laser, NanoLaser CETUS); for everything created under PURE, the spelling CETUS NanoLaser applies.
One brand, two forms
PURE is a brand without tiers. It has two forms that differ only in whether the device is named. Which form belongs on a surface is decided by the audience, not by taste.
Toward patients: practice, flyer, patient website, waiting room
Toward professional audiences: congress, trade advertisement, device, data sheet, sales
Which form where
| Surface | Form |
|---|---|
| Patients (practice, flyer, patient website, waiting room) | PURE alone |
| Professional audiences (congress, trade advertisement, device, data sheet, sales material) | PURE by CETUS |
| The device itself, single-use probe packaging | PURE by CETUS single-line |
| Footers, “PURE practice” seal, narrow headers | PURE by CETUS single-line |
| App icon, favicon, social avatar | Symbol alone |
- Never both forms on the same surface. A flyer is PURE, a data sheet is PURE by CETUS.
- “by CETUS” never stands alone. It is an addition, not a brand.
- “by CETUS” is never larger than 0.34 of the PURE cap height and always appears in steel, never in petrol or navy. It is meant to stay quiet.
- Both forms carry the same symbol, the same wordmark, the same colors.
On the former “pro” tier. The draft provided “NanoPURE pro” for the premium lens. The review finding of October 17, 2026 rated it yellow to red (impression of a better operation even though only the lens differs; Section 5 UWG, Section 3 HWG, Section 27 MBO). The decision of October 2026 has no tier. Should A.R.C. Laser decide on one later, it will be added following the same pattern. Until then: one brand, the choice of lens is named separately. See Open items.
Brand architecture
Three names, three roles. They are not mixed and do not replace one another. The device appears in the logo only as the endorsement “by CETUS”.
Procedure
PUREThe brand toward patients and practices. Laser instead of ultrasound in lens surgery, cataract and refractive lens exchange.
Device
CETUS NanoLaserThe product. In the logo only as “by CETUS”, named toward professional audiences, explained to patients as “the nanolaser”.
- On patient material PURE leads, A.R.C. Laser appears small as the sender, the nanolaser is explained in the text.
- On professional material PURE by CETUS leads, A.R.C. Laser as the sender.
- On practice material the practice is added: name, contact details, the practice logo on request. See Applications.
- The A.R.C. Laser brand portal (brand.arclaser.cloud) governs the sender. This portal governs everything called PURE.
Logo
The symbol
An arc and seven dots. The arc stands for the lens, the dots for its dissolution by the nanolaser. The dots continue the arc, become smaller and paler and dissolve toward the right. The symbol tells the procedure in one image, without an eye, without a beam, without a device. It is carried over unchanged from the draft.
Construction
- PURE: IBM Plex Sans 600, capitals, tracking minus 0.01 em, navy. To the right of the symbol, gap 0.38 of the symbol height, cap height 0.37 of the symbol height.
- by CETUS: “by” Plex Sans 400 lowercase, “CETUS” Plex Sans 500 capitals, letter-spaced 0.10 em. Cap height 0.34 of the PURE cap height. Steel
#7A8AA6on light,#AEBBD0on dark. - Two-line (main form): “by CETUS” below PURE, left-aligned with the P, distance between the PURE baseline and the cap line of by CETUS 0.30 of the PURE cap height.
- Single-line: “by CETUS” to the right of PURE on the same baseline, gap 0.55 of the PURE cap height.
- Reversed: arc and PURE in white, dots in mint. The dots keep their opacity.
The idea
Arc equals lens, dots equal dissolution. The symbol is a gesture, not a diagram.
The colors
Navy for trust, petrol for medicine and clarity. On a dark background, petrol becomes mint.
Versatile
Works small, in one color and on light as well as dark backgrounds. The dots keep their opacity.
Permitted versions
PURE wordmark
Symbol plus PURE. For patients. In color on light, reversed on dark.
PURE by CETUS two-line
Symbol, PURE, “by CETUS” below. Main form for professional audiences.
PURE by CETUS single-line
Everything on one baseline. For the device, packaging, footers, seals and narrow headers.
Lettering without symbol
PURE or PURE by CETUS as plain lettering. Only when the symbol already appears on the same surface or is technically not possible (engraving, embossing).
Symbol alone
For app icons, profile pictures, small areas and as a repetition when the wordmark already appears on the same page.
One color
All navy or all white when only one color is possible (stamp, engraving, fax, single-color print). The dots keep their gradation through opacity.
Clear space and minimum sizes
The unit of measure is x, the stroke width of the arc. The clear space all around is 2 x. Nothing is placed in this space: no text, no other logo, no image edge. For PURE by CETUS, the line “by CETUS” counts as part of the logo; the clear space begins below it.
| Version | Screen | |
|---|---|---|
| PURE wordmark | 120 px wide | 30 mm wide |
| PURE by CETUS two-line | 160 px wide | 40 mm wide |
| PURE by CETUS single-line | 220 px wide | 55 mm wide |
| Symbol alone | 24 px high | 6 mm high |
| App icon | 32 px edge length | not applicable |
Below these sizes the small dots become invisible and “by CETUS” becomes illegible. If there is less room, use PURE without the addition, the symbol alone, or leave out the logo and spell out the name.
What is not allowed
- Rearranging symbol and lettering, for example stacking the symbol above the lettering. Only the horizontal version exists.
- “by CETUS” on its own, larger than 0.34 of the PURE cap height, in petrol or navy, or anywhere other than below or to the right of PURE.
- PURE and PURE by CETUS on the same surface.
- Inventing a tier or an addition (“PURE pro”, “PURE plus”, “PURE Premium”).
- Moving, adding, removing or equalizing the dots. The dissolution is the message.
- Swapping the colors: no petrol arc with navy dots, no mint on white.
- Applying gradients, shadows, outlines, 3D effects or gloss to the logo.
- Placing the logo on busy photos, close-ups of eyes or surfaces with too little contrast.
- Reading the arc as the letter C or using it as a bracket around text.
- Combining the logo with the A.R.C. Laser logo or a practice logo into a new symbol.
- Retyping the lettering in another typeface. The lettering exists as a path and is used only as a file.
Design
Color
Two brand colors, one light color, lots of surface. Navy carries trust and text, petrol carries medicine, clarity and the accent. Mint is the light on a dark background. Everything else is light, matte and calm.
#13284ARGB 19 40 74
Trust. Text, headings, dark surfaces, the arc, the word PURE.
#1F6F6FRGB 31 111 111
Medicine, clarity. The dots, links, accents.
#8FD1C8RGB 143 209 200
Light. Dots and accents on a dark background. Never as text on white.
#DDEFECRGB 221 239 236
Calm surface. Boxes, highlights, table rows.
#F6F7F4RGB 246 247 244
Page background. Warm, matte light gray instead of pure white.
#FDFDFBRGB 253 253 251
Cards and surfaces that stand out from the background.
#4A5568RGB 74 85 104
Secondary running text, captions.
#7A8AA6RGB 122 138 166
The addition “by CETUS”, dimension lines, secondary text. Large sizes only. On a dark background
#AEBBD0.#DCE2E8RGB 220 226 232
Borders, dividers, table rules.
Distribution
Mist and paper dominate a page. Navy carries text and individual surfaces. Petrol is the accent and appears sparingly: dots, highlights, links, a button. Mint appears only on navy. There is no signal color in the brand system, no red, no orange, no gradient. Red appears only in interfaces where an actual error is reported.
Contrast
| Combination | Contrast | Use |
|---|---|---|
| Navy on mist | 13.7 : 1 | Any text |
| Petrol on white | 5.9 : 1 | Text from 14 px, links, eyebrows |
| Slate on mist | 7.0 : 1 | Any text |
| Steel on white | 3.5 : 1 | Large type only, from 24 px, or bold from 19 px, the addition “by CETUS” |
| Mint on navy | 8.5 : 1 | Text and accents on a dark background |
| Mint on white | 1.7 : 1 | No type. Only as a surface or dot. |
| White on petrol | 5.9 : 1 | Buttons and surfaces with text |
For offset printing the values in the color package are approximations. Before a print run, check a press proof against the screen color; navy tends toward violet in CMYK, petrol toward green. Pantone values have not yet been defined, see Open items.
Type
Two sans serifs with a clear division of labor: Geist for headings, guiding statements and subheadings, IBM Plex Sans for text, tables, interfaces and the lettering. Geist is smooth and restrained and gives the brand a competent, friendly voice without playfulness; Plex Sans keeps long texts legible. Both are freely available (SIL Open Font License), so they can be used in print, web and practice material without license fees. Decided on October 31, 2026; before that, IBM Plex Serif was intended for headings.
Laser instead of ultrasound.
Geist Medium for headings, IBM Plex Sans Regular for text. Numerals 0123456789, umlauts äöüß.
Geist as a variable font from 100 to 900, used in 500. Plex Sans as a variable font from 100 to 700, used in 400, 500 and 600.
Rules
- Headings in Geist, Medium weight (500), letter-spacing minus 0.015 em, never bold. Capitals only in the eyebrow and in the brand name.
- Running text in Plex Sans Regular, line length 55 to 75 characters, line height 1.5 to 1.65.
- Emphasis in text with Semibold (600), not with color, not with underlining.
- Eyebrows in Plex Sans Semibold, capitals, letter-spaced by 0.12 em, in petrol.
- No italics for headings. Italics only for foreign words and third-party brand names in text.
- PURE in running text in the same typeface and size as the sentence, no special treatment, capitals only.
Substitutes in Office and email
Where Geist and IBM Plex cannot be installed (email clients, third-party computers), the rule is: Arial for headings and text, headings not bold, only larger. For Microsoft Office at the practice, the typeface is included in the font package and installed once. Never mix in Calibri or Times New Roman.
Brand element: the dots
The dissolving dots from the symbol are the element that connects all applications. They run as a pattern along the edge of an image, as a divider between sections, as a background on dark surfaces and as motion on screen. They always tell the same story: something dissolves.
- The pattern fades out, it never fills an entire surface. The density decreases in one direction.
- In print, at most one edge per page. On screen, one edge per stage.
- As a divider between sections, a short row of dots that disappears toward the right. No solid lines.
- In motion the dots appear one after another, without a jump. Users who prefer reduced motion see the result immediately.
- The dots are never decoration on photos of people and never on the eye.
Imagery
Light, calm, approachable: life with good vision. The images do not show the procedure but what becomes easy again afterward. People in their fifties and sixties, natural light, plenty of white space, muted colors that go with navy and petrol.
Premium moments
Golf, sailing, art gallery, museum. Main motifs of patient communication.
Everyday life
Reading on a tablet, driving at dusk. Supplementary, for example in social media.
Trust
Physician and patient in conversation as equals, calm practice atmosphere. Consultation, brochure, physician finder.
Technology
CETUS and the single-use probe, photographed brightly, with plenty of white space. Professional audiences, trade shows, product pages, always with PURE by CETUS.
| Like this | Not like this |
|---|---|
| Real people, real practices, with consent | Actors as physicians, stock photos with white coats and crossed arms |
| Soft depth of field, natural light, warm skin tones | Blue studio lighting, high gloss, hard shadows |
| The result: reading, driving, seeing | Eye close-ups with laser beams, surgical scenes in patient communication |
| The device light and calm, as a tool of the practice | The device as a hero with light effects |
| A person taking off their glasses and reading | Glasses being thrown away, before-and-after images |
Until real photos are available, no illustrations or AI images are used as a substitute in printed material. For drafts, placeholders with a color surface and an image description are correct. The photo production is an open item.
Language
Tone and messages
PURE explains. Short sentences, active verbs, concrete words. The patient is addressed directly as “you”, never as “patients” in a direct conversation. Technical terms are translated, not avoided: “the natural lens is dissolved and aspirated” instead of “lens fragmentation”.
| We say | We do not say |
|---|---|
| gentle, careful (only with a footnote), calm | revolutionary, unique, painless, risk-free |
| laser instead of ultrasound | better than ultrasound, the better method |
| your natural lens is dissolved and aspirated | shattered, destroyed, vaporized |
| cataract, age-related loss of near vision | phacoemulsification, presbyopia (in patient text without explanation) |
| your eye doctor discusses with you whether the procedure is suitable for you | suitable for everyone, without side effects |
| premium lens, standard lens | luxury lens, cheap lens, insurance lens |
| laser pulse, light instead of ultrasound | precise, pure (as a promise of purity or freedom from side effects), nothing but light |
Two audiences, one brand
Toward patients, PURE talks about the experience: without ultrasound, the familiar workflow, the lens is dissolved and aspirated. Toward professional audiences, PURE by CETUS talks about clinical results and workflow: energy input, endothelium, single-use probe, compatibility. Both levels carry the same symbol and the same colors, but never the same sentences and never the same logo form. Professional arguments do not belong on patient material.
Claims
The claims are facts that can be verified, not efficacy claims. They are used verbatim and not varied. Further languages are derived from the English version and reviewed for each country.
Patients, Germany
Laser statt Ultraschall.
Linsenchirurgie ohne Ultraschall
Patients, international
Laser instead of ultrasound.
Lens surgery without ultrasound
Surgeons, Germany
100 % Laser. 0 % Ultraschall.
Linsenchirurgie mit dem CETUS NanoLaser
Surgeons, international
100 % laser. 0 % ultrasound.
Lens surgery with the CETUS NanoLaser
Traffic light
| Sentence | Rating | Use |
|---|---|---|
| Laser instead of ultrasound. | established fact | Patients and professional audiences, verbatim |
| Lens surgery without ultrasound. | established fact | Patients and professional audiences, verbatim |
| 100 % laser. 0 % ultrasound. | established fact | Professional audiences; appears this way on arclaser.de |
| Sanft zum Auge. / Gentle on the eye. | with caution | Efficacy claim. Only with a footnote and approval by legal counsel, not as the main message |
| Nothing but light. | removed | The mechanism of action is photomechanical (plasma, pressure wave), not “light only”. Do not introduce. |
| Your premium lens deserves a gentle procedure. | removed | Link to an out-of-pocket service, efficacy promise |
| precise | removed | No data on precision, argument of the femtosecond laser |
| Result: lower endothelial cell loss | not like this | Not defensible as the main message (RCT Sauder 2024 not significant). Professional audiences: “Lower endothelial cell loss in studies” with a footnote |
| pure | removed | As a promise of purity or freedom from side effects. PURE is explained only as “purely laser, no ultrasound” |
Arguments for professional audiences
Clinical
- No ultrasonic oscillation of the needle
- No ultrasonic heat at the incision1
- Lower energy input1
- Lower endothelial cell loss in studies1
Workflow
- Single-use probe: ready to use immediately, no reprocessing risk
- Uses the existing fluidics, the familiar workflow remains
- Compatible with common phaco systems2
1 Footnote under Section 6 HWG: Tanev 2016 (J Cataract Refract Surg 42:725) and Zbiba 2023 (Front Med, DOI 10.3389/fmed.2023.1097404), with the note that the randomized study Sauder 2024 did not find the difference significant. 2 The compatibility list is maintained by A.R.C. Laser and cited on the material. Both details must be inserted before printing, see Regulatory.
Origin of the rating. Review of October 17, 2026 (evidence file) and of October 29, 2026 (name check PURE and CETUS), carried over into the decision of October 2026. The professional wording above is already the reviewed version (in the draft: “No vibration”, “No thermal stress”, “Result: lower endothelial cell loss”). Final approval by the legal counsel of A.R.C. Laser.
Style rules
- German texts use real umlauts and ß, never ae, oe, ue or ss as substitutes.
- No dashes as punctuation. Use a comma, a colon or two sentences instead. The middle dot (·) separates keywords in footers.
- Quotation marks: German „so“, English “so”.
- Numbers in text spelled out up to twelve, percent with a space (2.1 %, in German 2,1 %), units with a space (6 mm).
- PURE, PURE by CETUS, CETUS NanoLaser, A.R.C. Laser: always exactly like this. No emojis, no exclamation marks in headings.
- English in American spelling (color, center), like the other English materials of A.R.C. Laser.
- People are referred to as patients and physicians. German texts name both forms (Patientin und Patient, Ärztin und Arzt) without special characters inside the word.
Use
Regulatory
PURE advertises a medical procedure performed with a medical device. This is governed by the German Health Advertising Act (Heilmittelwerbegesetz, HWG), the Medical Device Regulation (MDR, Article 7), the German Unfair Competition Act (UWG) and, for the practices, the professional code for physicians. A.R.C. Laser reviews and approves every piece of material before a practice uses it. Practices do not alter approved texts.
Do not mislead
Do not promise any effect that is not substantiated. No statement that success is certain. No disparagement of other procedures.
Advertising to the public
Toward patients: no fear-based advertising, no before-and-after images for surgical procedures, no statements by physicians as endorsements, no foreign technical terms without explanation.
Cite the evidence
Clinical statements carry author, year and journal. Quotations from the literature verbatim and with source. The state of the evidence is presented in full, including where it is inconsistent.
Name the sender
A.R.C. Laser GmbH as the manufacturer, the practice as the treating party. Advertising is recognizable as such, including in social media.
The name itself
“Pure” means clean, unmixed. As soon as material lets “pure” be understood as sterile, free of side effects or free of complications, it is an efficacy claim without evidence (Section 3 sentence 2 nos. 1 and 2 HWG, MDR Art. 7(a) and (c)). That is why PURE is explained everywhere as “purely laser, no ultrasound” and never otherwise. Added to this is a conflict with trademark law: the more strongly PURE is explained in advertising as a statement of characteristics, the more descriptive it is as a trademark, see Trademark check.
The planned statements
Classification under the German Health Advertising Act, the UWG, MDR Article 7 and professional law, as of October 17, 2026, supplemented on October 29, 2026. The basis is the evidence file of this portal (state of the studies, legal framework with references). Final approval rests with the legal counsel of A.R.C. Laser. For efficacy claims the strict standard of the German Federal Court of Justice applies: substantiated means randomized and controlled.
| Statement | Audience | Rating | Reasoning and reviewed version |
|---|---|---|---|
| Laser instead of ultrasound | Patients | usable | Accurate description, permissible comparison (Section 6 UWG). A note is required that ultrasound may be needed in addition for hard nuclei (Section 5a UWG, MDR Art. 7(c)). |
| Lens surgery without ultrasound | Patients | usable | Fact. Same note on conversion for hard nuclei. |
| 100 % laser. 0 % ultrasound. | Professionals | usable | Fact, appears this way on the manufacturer’s website. Conversion at LOCS 4 and higher goes into the fine print. |
| Sanft zum Auge. / Gentle on the eye. | Patients | with caution | Efficacy claim without a measurable quantity, mixed endothelial evidence (Section 3 no. 1 HWG). Implies that ultrasound is not gentle (Section 11 no. 7 HWG, Section 6 UWG). Only with a footnote and approval. |
| hornhautschonend / cornea-friendly | Patients | with footnote | Only as a study result with source (Tanev 2016, Zbiba 2023), not as a property. Not defensible in advertising to the public without a footnote. |
| Endothelium-sparing. | Professionals | with footnote | “Endothelium-sparing in studies*” with a footnote under Section 6 HWG and honest mention of the non-significant RCT 2024. |
| Nothing but light | all | removed | The pulse hits a titanium tip, a microplasma forms there, and the lens is fragmented by the pressure wave. The mechanism of action is photomechanical (MDR Art. 7(b)). Permissible: “Light instead of ultrasound”, “Laser pulse instead of ultrasound”. |
| pure, PURE as a promise of purity | Patients | removed | A “pure procedure” in the sense of sterile or free of side effects is a claim of success without evidence (Section 3 sentence 2 nos. 1 and 2 HWG). Explain PURE only as “purely laser, no ultrasound”. |
| Your premium lens deserves a gentle procedure. | Patients | removed | Efficacy promise plus link to an out-of-pocket service, promotional for practices (Sections 3 and 11 no. 7 HWG, Section 5 UWG, Section 27 MBO). |
| Precise and gentle lens surgery with a premium claim | Brand core | “precise” removed | No study measures precision; precision is the argument of the femtosecond laser (Section 3 no. 3a HWG, MDR Art. 7(b)). “Gentle” yellow as above. |
| No vibration | Professionals | reworded | Accurate as “no ultrasonic oscillation of the needle”. Shock waves and cavitation also occur with the laser. |
| No thermal stress | Professionals | reworded | Substantiated only as: no ultrasonic heat at the incision. Plasma generates local heat, in vivo measurements have not been published. |
| Lower energy input* | Professionals | with footnote | Consistently substantiated: 1.2 J versus 38.5 J (Sauder 2024), 2.16 J versus 245 J (Zbiba 2023). Phrase in orders of magnitude, not as a factor. |
| Result: lower endothelial cell loss* | Professionals | not like this, reworded to yellow | “Result” asserts established causality; the RCT 2024 did not find the difference significant, Juhás 2019 found equivalence. Permissible: “Lower endothelial cell loss after 24 months in two prospective comparative studies (Tanev 2016: 4.0 % versus 9.1 %; Zbiba 2023: 12.7 % versus 20.2 %).” |
| Single-use, ready to use immediately, no reprocessing risk | Professionals | usable | Product property. Refer to the probe only. No statements such as “never an infection” (Section 3 no. 2b HWG). |
| Uses the existing fluidics, the familiar workflow remains | Professionals | with qualification | Accurate. A dedicated program on the phaco machine, longer fragmentation time, more irrigation fluid and a learning curve are part of it. |
| Compatible with common phaco systems** | Professionals | with list | Without a published device list, “common” is indeterminate (Section 5 UWG). Request the list from A.R.C. Laser. |
| For cataract and presbyopia | Patients | reworded | Presbyopia is corrected by the lens, not by the laser (Section 3 no. 1 HWG, MDR Art. 7(a)). Version: “For cataract and for lens exchange in presbyopia”, subject to the intended purpose. |
| Tier with premium lens (formerly “pro”) | Patients | not part of the decision | Impression of a better operation, accusation of commercialization. PURE has no tier, see One brand, two forms. |
| Statements by physicians, patient testimonials | Patients | not toward patients | Endorsements by healthcare professionals (Section 11 no. 2 HWG). For professional audiences with name, profession, place and date (Section 6 no. 1). Quotations with efficacy claims (“never an infection”) in no material at all. |
State of the evidence in brief
There is no meta-analysis and no systematic review on the nanolaser. Consistently substantiated is the energy input that is one to two orders of magnitude lower. Whether this leads to less endothelial cell loss is plausible but not established: the only published randomized, masked study misses this endpoint. Equally substantiated are the limits: longer fragmentation time, more irrigation fluid, hard nuclei, learning curve. They belong in the material (MDR Art. 7(c), Section 5a UWG).
| Study | Design | n | Endothelial cell loss, laser versus ultrasound | Strength of evidence |
|---|---|---|---|---|
| Sauder et al. 2024, EC Ophthalmology | randomized, double-masked, 84 days | 68 eyes | 3.5 % versus 7.3 %, not significant; energy 1.2 J versus 38.5 J | high in design, short follow-up, journal not in PubMed |
| Zbiba et al. 2023, Frontiers in Medicine | randomized, unmasked, 24 months | 74 eyes | 12.7 % versus 20.2 %, p < 0.01; surgery time 12.0 versus 10.1 min | medium, independent |
| Tanev et al. 2016, J Cataract Refract Surg | prospective, fellow eye, 2 years | 82 eyes | 4.0 % versus 9.1 %, p < 0.001 | medium, independent, not randomized |
| Juhás 2019, Cesk Slov Oftalmol | fellow eye, 7 days | 40 eyes | 13.5 % versus 19 %, not significant, “equivalent” | low, dissenting voice |
| Breyer et al. 2025, ESCRS | retrospective, 5 years, no control | 30 eyes | 11.8 % after five years (with pre-chop and soft shell) | low |
| Sauder 2019, ASCRS (Healio) | congress report | 72 patients | 2.1 % versus 7.2 % after one year, no p-values | no peer review, not as primary evidence |
What is still missing from the material
- Labeling as advertising and naming the sender on every patient piece (Section 11 no. 9 HWG, Section 5a UWG).
- Notes on risks and limits: longer surgery time, possible conversion to ultrasound for hard nuclei, capsule rupture as in any cataract surgery, no guarantee of spectacle independence.
- Separation of manufacturer and practice: practices may not advertise on behalf of a manufacturer (Section 27 (3) MBO). Practice material is the practice’s own procedure information; A.R.C. Laser appears in the legal notice and the technology note, not as the advertising sender. This is why PURE appears toward patients without “by CETUS”.
- Physician finder with a note that a listing is neither a recommendation nor a certification (following Alcon’s example), and with published listing criteria. No fee, no advantage for the listing.
- Source sheet that accompanies every version of the material, and a documented approval per version under the MDR (date, reviewer).
- Brand license agreement per practice: scope, design rules, approval, revocation.
Trademark check
Search of October 29, 2026 in TMview (ten offices: EUIPO, DPMA, WIPO, France, Spain, Italy, United Kingdom, Switzerland, Austria, USA), lists of goods via the EUIPO data interface, plus domain lookups. Checked were PURE alone, CETUS alone and the combination. TMview is not an official register; the hits must be verified by legal counsel. This portal reports the finding; it is not legal advice. The full check is available at Name check PURE and CETUS (German).
Key finding: PURE as a word mark on its own rates red, CETUS does not belong to A.R.C. Laser as a trademark, the combination is free. EU word marks PURE exist in class 10 (EndyMed Medical, EM 018919283) and class 44 (Prodeon Medical, EM 018687194); in total 36 identical live PURE marks in classes 10 and 44. In class 10, Invacare holds the word mark CETUS (EM 018066484). For “PURE by CETUS” and “PURE CETUS” there is no hit in any office.
PURE
| Trademark | Office, number | Owner | Classes | Status | Relevance |
|---|---|---|---|---|---|
| PURE (word) | EUIPO 018919283 | EndyMed Medical Ltd. | 10 | registered 2023 | identical, class 10 (RF aesthetic device); grace period until 10/2028 |
| PURE (word) | EUIPO 018687194 | Prodeon Medical Corporation | 44 | registered 2022 | identical, class 44 (prostate clinic) |
| PURE (figurative) | EUIPO 011130028 | BioCer Entwicklungs-GmbH | 5, 10 | registered 2013 | broad heading “surgical and medical apparatus and instruments” |
| PURE (word) | DPMA 307603857 | Sivantos GmbH (Signia) | 10 | registered 2007 | Germany, hearing aids, actively used |
| TECNIS PURESEE | EUIPO 018669702 | Johnson & Johnson Surgical Vision | 10 | registered | intraocular lens, implanted in the same operation |
| PUREPOINT | EUIPO 006248637, WO 917085 | Alcon Inc. | 10 | registered | ophthalmic surgical laser |
| IsoPure, IPURE | EUIPO 017762469, 009596867 | PhysIOL (BVI) | 5, 10 | registered | premium intraocular lenses |
| PUREVISION, PURE-LINE | EUIPO 003279825, 018408134 | Bausch + Lomb | 5, 9, 10 | registered | contact lenses, cataract surgery kits |
| 32 further identical PURE | DE, FR, GB, US, WO | among them Siemens Healthineers, Pure Sports Medicine, Ortho Technology | 10, 44 | live | check country by country |
On registrability: “Pure” is an everyday word and promotional as a statement of quality. The German Federal Patent Court (BPatG) has regularly rejected PURE and compounds as lacking distinctiveness (24 W (pat) 9/09, 27 W (pat) 86/14, 25 W (pat) 16/21), and the EUIPO likewise “100% PURE”, “PURE POWER” and “ULTRAPURE”. For devices where “pure” does not describe a property, it went through (EndyMed, Prodeon, Sivantos). For a laser procedure that is explained as “purely laser, no ultrasound”, PURE describes exactly the advertised property. Protection therefore lies in the symbol and in the combination, not in the word.
CETUS
| Trademark | Office, number | Owner | Classes | Status | Relevance |
|---|---|---|---|---|---|
| CETUS (word) | EUIPO 018066484, GB, CH, WO 1497310 | Invacare International GmbH | 10, 12 | registered 2019, protected until May 17, 2029 | class 10 with “surgical and medical apparatus and instruments”; the name is used for a mobility scooter. Grace period expired on September 26, 2024, partial revocation under Art. 58 EUTMR conceivable |
| A.R.C. Nano Laser (word) | EUIPO 018035440, GB, WO 1471295 | A.R.C. Laser GmbH | 10 | registered 2019, protected until March 13, 2029 | the only A.R.C. Laser trademark found; “CETUS”, “NanoLaser CETUS” and “CETUS NanoLaser” are not filed |
| CETUS (word) | EUIPO 010424497, 007161961, 009738221, 019194998 | Würth, Zumtobel, FMC, ABRIS | 1, 5, 9, 11, 12, 42 | registered | other classes, low |
Combination and domains
| Check | Finding |
|---|---|
| “PURE by CETUS”, “PURE CETUS”, “PURE VERFAHREN” in TMview, all classes | 0 hits, free as a composite sign |
| purebycetus.de, .com, .eu, .health | available (as of October 29, 2026) |
| pure-cetus.de, .com, .eu; cetus-pure.de, .com; pureverfahren.de, pure-verfahren.de | available |
| pure.health, cetus.de, cetus.com | taken |
The old name
The check of October 17, 2026 had found an identical EU figurative mark in class 10 for NanoPURE (“nanopure”, EUIPO 018351781, Wintek Trading (Ningbo), classes 9 and 10, protected until 2030), plus parallels in the United Kingdom, Japan and Canada, and in the USA the laboratory brand NANOPURE of Thermo Fisher; nanopure.de, .eu and .com were taken. That was one of the reasons for the change of name.
Recommended path
- File a combined word and figurative mark “PURE” with the symbol. The symbol carries the distinctiveness that the word alone lacks. Classes 10 and 44 mandatory, consider 41, 35 and 9.
- Secure CETUS as a word mark in 10 and 44. Beforehand, document earlier rights (use for more than ten years: invoices, trade shows, CE documentation) and have the partial revocation of Invacare EM 018066484 for “surgical apparatus” examined.
- Have it examined whether “A.R.C. Nano Laser” (EM 018035440) is used in a rights-preserving way in the form “CETUS NanoLaser” (Art. 18 EUTMR).
- Likelihood of confusion of the composite sign against the PURE marks (EndyMed, Prodeon, BioCer, Sivantos) and against CETUS (Invacare) to be assessed; the initial word PURE is considered dominant.
- In the market: Johnson & Johnson, Alcon, Bausch + Lomb and PhysIOL use “Pure” as a name component in the same operation. The risk is more one of unfair competition law (misleading as to origin) than of trademark law and argues for the symbol as the main carrier of the brand.
- Do not file anything yourself, do not contact anyone. No domain purchases before the search. That is a matter for the legal counsel of A.R.C. Laser.
Applications
A shared presence consists of four components. Everything is created centrally at A.R.C. Laser; the practices only add their name and contact details.
Brand presence
Name, logo, claim, imagery and colors. This portal.
Patient information
Brochure, explanatory video, material for the waiting room. Always PURE alone.
Digital components
Website texts, templates for social media, physician finder for patients.
Practice support
Training for the consultation, templates for press and events.
Roll-up banners, 85 × 200 cm
Two roll-ups, one for patients (PURE), one for physicians (PURE by CETUS). The sketches show structure and hierarchy, not the print file. Before printing: photos instead of color surfaces, study references, compatibility list, practice details, print files with bleed in CMYK.
For cataract and for lens exchange in presbyopia
Laser instead of ultrasound.
Lens surgery without ultrasound
With the nanolaser, your natural lens is dissolved and aspirated, without ultrasound. The familiar course of the operation remains. Whether the procedure is suitable for you is something your eye doctor discusses with you.
[Practice name] · PURE practice · Advertising · Procedure with a medical device from A.R.C. Laser GmbH
Lens surgery with the CETUS NanoLaser
100 % laser.
0 % ultrasound.
Clinical
- No ultrasonic oscillation of the needle
- No ultrasonic heat at the incision*
- Lower energy input*
Lower endothelial cell loss in studies*
Workflow
- Single-use probe, ready to use immediately
- Uses the existing fluidics
- Compatible with common phaco systems**
* Tanev 2016, Zbiba 2023; Sauder 2024 not significant · ** Compatibility list · A.R.C. Laser GmbH
Adapting practice material
What the practice may change
- Practice name, address, phone, website in the designated field
- Its own practice logo in the footer area, at clear-space distance from the PURE wordmark
- The language, from the approved versions
What stays as it is
- Claims, texts and footnotes
- Logo, logo form (PURE or PURE by CETUS), colors, type, imagery
- Order and hierarchy of the content
- Own photos of procedures or eyes
Digital
- Practice website: one approved text module with the PURE wordmark, claim, three paragraphs and a reference to the consultation. No own text about efficacy.
- Social media: templates in square and portrait format, imagery as above, dot pattern along one edge, wordmark bottom left, practice name bottom right. Advertising is labeled as such. The avatar is the symbol alone.
- Physician finder: patients find partner practices through a central page run by A.R.C. Laser. Every practice that uses the material is listed there.
- Video: the explanatory video comes from A.R.C. Laser, with subtitles in the respective language. Practices do not edit it.
- Device and packaging: PURE by CETUS single-line, in one color, navy or white, at clear-space distance from the manufacturer logo.
Roles and rollout
A.R.C. Laser
- Leads the brand and develops it further
- Creates content and templates in both logo forms
- Reviews and approves everything for regulatory compliance
- Rolls the brand out internationally through distributors
Users
- Use the materials in their own practice
- Adapt locally: practice name and contact details
- Give feedback and share experience
- Become visible in the physician finder
International
Developed once, usable in all markets. The content is created in German and English; further languages are translated from the English. PURE and “by CETUS” are not translated. Distributors receive a uniform package (logo, colors, type, templates, texts) and have it reviewed under the advertising and medical device law of their country before it is used. Whatever changes in that process goes back to A.R.C. Laser so that the brand stays the same in every country.
Files
Source files
All files follow the decision of October 2026. They may be used for drafts, coordination and the pilot, not for print runs, until A.R.C. Laser has approved the portal.
Status and maintenance
This portal is the single source. Whoever changes a rule changes it here, in the German version and in the text version for AI tools. Questions and approvals: Christin Bartlog (product management), Maximilian A. Grimm (IT and portal).
| Date | What |
|---|---|
| User Meeting 2026 | Discussion draft by Christin Bartlog and Zoe Geiß under the name NanoPURE: symbol, colors, claims, imagery, roles. |
| October 17, 2026 | Portal created. Logo reconstructed as vector, color system, type, brand element, rules, download packages. Evidence file: procedure, state of the studies, advertising law, trademark check; from these the review findings and the list of changes. |
| October 29, 2026 | Name check PURE and CETUS: registers in ten offices, lists of goods, domains, case law. “Nothing but light” removed. |
| October 2026 | Decision by A.R.C. Laser: the name is PURE, variation PURE by CETUS, symbol, colors and typefaces stay, no tier. |
| October 31, 2026 | Portal switched to PURE: name, two logo forms, construction of “by CETUS”, claims, trademark check, files. New address purebrand.arclaser.cloud, the old portal remains as an archive. |
Changes from the draft
What this portal defines differently from the discussion draft of the user meeting, and why. The name and the logo system are binding through the decision of October 2026. The remaining rows are proposals to Christin Bartlog and Zoe Geiß that become binding with the approval of the portal.
| In the draft | Here | Reason |
|---|---|---|
| Name NanoPURE | PURE, toward professional audiences PURE by CETUS (binding) | Shorter, device reference optional, the old name collides with the EU figurative mark “nanopure” in class 10 |
| Wordmark “Nano” and “PURE” in two colors, addition “pro” | One word in navy, addition “by CETUS” in steel, two-line or single-line (binding) | Decision of October 2026 |
| Acronym P, U, R, E (Precise, Ultrasound-free, Resolution, Extraction) | Not continued; PURE stands for “purely laser, no ultrasound” | “Precise” not substantiated, acronym not part of the decision |
| Result: lower endothelial cell loss* | Lower endothelial cell loss in studies*, footnote Tanev 2016 and Zbiba 2023 | RCT 2024 not significant, “result” asserts causality |
| Precise and gentle; P = Precise | “Precise” removed | No data on precision, confusion with the femtosecond laser |
| Your premium lens deserves a gentle procedure. | Removed; guiding statement “Laser instead of ultrasound.” | Link to an out-of-pocket service, efficacy promise |
| Sanft zum Auge. / Gentle on the eye. | Only with caution, footnote and approval; the main messages are the established facts | Efficacy claim without a measurable quantity |
| No vibration, no thermal stress | No ultrasonic oscillation of the needle, no ultrasonic heat at the incision | Only this is substantiated |
| For cataract and presbyopia | For cataract and for lens exchange in presbyopia | Presbyopia is corrected by the lens, not by the laser |
| “pro” tier for the premium lens | One brand without tiers, name the lens choice separately | Impression of a better operation, professional law; not part of the decision |
| Roles: users use the materials | Plus brand license agreement and approval process per version | MDR Art. 7, liability, revocation |
| Outlook: feedback, concept, pilot, rollout | Trademark search and filing strategy before the pilot | PURE as a word mark red, CETUS not registered |
Open items
- Attorney trademark search PURE and CETUS and filing strategy: combined word and figurative mark PURE with the symbol, CETUS as a word mark in 10 and 44, document earlier rights, examine partial revocation against Invacare. See Trademark check. No filing and no contact beforehand.
- Tier (formerly “pro”): not part of the decision. Until A.R.C. Laser decides otherwise, one brand without tiers. If it does, clear the wording in advance with an attorney and a state medical association.
- Photo production for the four motif worlds. Until then, no illustrations or AI images in print.
- Pantone values and press proof for navy and petrol.
- Practice package: templates for roll-up, brochure, website module and social media as editable files, each in the correct logo form.
- Brand license agreement per practice drafted by an attorney; budget and responsible persons for HWG, MDR and trademark review.
- Approval of the portal by A.R.C. Laser (Christin Bartlog).
Open on the evidence side since October 17, 2026
- Operating manual Rev. 2 as an actual file (the files on hand are placeholders): intended purpose verbatim, indications, technical data (pulse duration 4, 5 or 7 ns, repetition rate 10 or 25 Hz), laser class, warnings.
- Regulatory status: MDD or MDR certificate, notified body, validity; FDA 510(k) yes or no (sources contradict each other). Does the intended purpose cover refractive lens exchange? Otherwise remove “presbyopia” (MDR Art. 7(d)).
- Study footnotes. Recommendation Tanev 2016 and Zbiba 2023, plus Sauder 2024 with a note on the non-significant endpoint. The Healio figure (2.1 % versus 7.2 %) not in patient material. Obtain the full texts of Augenspiegel 2014 and 2018.
- Conflicts of interest of the cited authors to be disclosed (Section 6 HWG, credibility).
- Physician quotations and patient testimonials: which are dated, approved in writing and free of efficacy claims? Approval process with consent.
- Physician finder: listing criteria, disclaimer, no fee. Clarify the relationship to nanolaser.de: replace, supplement or subordinate. Two patient brands side by side make no sense.
- Compatibility list of phaco systems from product management.
- Spelling of the device on arclaser.de and arclaser.com to be unified (CETUS NanoLaser) so that “by CETUS” rests on a fixed name.
- English version of this portal under /en/ to be kept in step with the German version.